CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to tackle cancer cell diversity by identifying early genetic changes in cancer cells that contribute to tumor progression. By studying a specific group of disseminated cancer cells, the research seeks to develop targeted therapies that address the unique characteristics of individual cancers, particul…
Cancer drugs are extremely ineffective, generally because current therapies do not address cellular heterogeneity.
While hypothesis-driven research and functional genomics identify ever more novel putative therapeutic targets, the scientific community lacks rationales to attack the cellular heterogeneity in cancer, to select among the targets the most promising, and to design combination therapies.
In particular, these all fail to provide successful adjuvant therapy settings after curative resec…
UNIVERSITAET REGENSBURG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
